FDA Inspection 1175500 — Cell Therapies Manufacturing Facility Hackensack University Medical Center
The FDA completed an inspection of Cell Therapies Manufacturing Facility Hackensack University Medical Center on Jul 14, 2022 in Hackensack, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 14, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Hackensack, NJ (United States)